mRNA Expression Level of ALK in Neuroblastoma Is Associated with Histological Subtype, ALK Mutations and ALK Immunohistochemical Protein Expression
<i>ALK</i> is related to poor survival in neuroblastoma patients. We investigated the prognostic relevance of <i>ALK</i> mRNA expression and the relationship with ALK immunohistochemical expression, histological subtype and <i>ALK</i> aberrations. Whole transcript...
Saved in:
Main Authors: | Rixt S. Bruinsma (Author), Marta F. Fiocco (Author), Wendy W. J. de Leng (Author), Lennart A. Kester (Author), Karin P. S. Langenberg (Author), Godelieve A. M. Tytgat (Author), Max M. van Noesel (Author), Marc H. W. A. Wijnen (Author), Alida F. W. van der Steeg (Author), Ronald R. de Krijger (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2024-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The ALK inhibitor PF-06463922 is effective as a single agent in neuroblastoma driven by expression of ALK and MYCN
by: J. Guan, et al.
Published: (2016) -
Prognostic role of ALK-1 and h-TERT expression in glioblastoma multiforme: correlation with ALK gene alterations
by: Dalia Elsers, et al.
Published: (2021) -
Entrectinib and other ALK/TRK inhibitors for the treatment of neuroblastoma
by: Pacenta HL, et al.
Published: (2018) -
Therapeutic Targeting of the Anaplastic Lymphoma Kinase (ALK) in Neuroblastoma-A Comprehensive Update
by: Annette K. Brenner, et al.
Published: (2021) -
Uterine mesenchymal tumors harboring ALK fusions and response to ALK-targeted therapy
by: Chrisann Kyi, et al.
Published: (2021)